Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F Orntoft

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
British Journal of Cancer|August 18, 2005
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomasP Pallante, M T Berlingieri, G Troncone, et al.
Cancer Research|October 15, 1996
Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomasJ E Celis, M Ostergaard, B Basse, et al.
Oncogene|November 17, 2009
miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumorsM S Ostenfeld, J B Bramsen, P Lamy, et al.
Endocrine-Related Cancer|October 5, 2007
No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasiaA Raitila, M Georgitsi, A Karhu, et al.
The Journal of Biological Chemistry|December 13, 1996
Influence of Lewis alpha1-3/4-L-fucosyltransferase (FUT3) gene mutations on enzyme activity, erythrocyte phenotyping, and circulating tumor marker sialyl-Lewis a levelsT F Orntoft, E M Vestergaard, E Holmes, et al.
British Journal of Cancer|October 8, 2011
Low ANXA10 expression is associated with disease aggressiveness in bladder cancerP P Munksgaard, F Mansilla, A-S Brems Eskildsen, et al.
Diabetologia|December 4, 2004
Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1beta-mediated toxicity through inhibition of multiple nuclear factor-kappaB-regulated proapoptotic pathwaysA E Karlsen, P E Heding, H Frobøse, et al.
Oncogene|August 29, 2012
A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage responseT Schepeler, P Lamy, V Hvidberg, et al.
British Journal of Cancer|September 15, 2012
Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCRL Dyrskjøt, T Reinert, A Novoradovsky, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 24, 2004
A genome-wide search for risk genes using homozygosity mapping and microarrays with 1,494 single-nucleotide polymorphisms in 22 eastern Cuban families with bipolar disorderH Ewald, F P Wikman, B M Teruel, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
British Journal of Cancer|August 18, 2005
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomasP Pallante, M T Berlingieri, G Troncone, et al.
Cancer Research|October 15, 1996
Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomasJ E Celis, M Ostergaard, B Basse, et al.
Oncogene|November 17, 2009
miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumorsM S Ostenfeld, J B Bramsen, P Lamy, et al.
Endocrine-Related Cancer|October 5, 2007
No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasiaA Raitila, M Georgitsi, A Karhu, et al.
The Journal of Biological Chemistry|December 13, 1996
Influence of Lewis alpha1-3/4-L-fucosyltransferase (FUT3) gene mutations on enzyme activity, erythrocyte phenotyping, and circulating tumor marker sialyl-Lewis a levelsT F Orntoft, E M Vestergaard, E Holmes, et al.
British Journal of Cancer|October 8, 2011
Low ANXA10 expression is associated with disease aggressiveness in bladder cancerP P Munksgaard, F Mansilla, A-S Brems Eskildsen, et al.
Diabetologia|December 4, 2004
Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1beta-mediated toxicity through inhibition of multiple nuclear factor-kappaB-regulated proapoptotic pathwaysA E Karlsen, P E Heding, H Frobøse, et al.
Oncogene|August 29, 2012
A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage responseT Schepeler, P Lamy, V Hvidberg, et al.
British Journal of Cancer|September 15, 2012
Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCRL Dyrskjøt, T Reinert, A Novoradovsky, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 24, 2004
A genome-wide search for risk genes using homozygosity mapping and microarrays with 1,494 single-nucleotide polymorphisms in 22 eastern Cuban families with bipolar disorderH Ewald, F P Wikman, B M Teruel, et al.
Pageof 10